Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2020

Aug 27, 2020

29821_dirs_2020-08-27_2cd366cf-1d4b-42e5-b4d0-25b50f34b191.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-08-26

Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-26 Common Stock S 7750.0000 $38.9844 Disposed 10299.0000 Direct

Footnotes

F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.1812 to $39.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.